Hudson Portfolio Management LLC Invests $2.68 Million in CVS Health Corporation $CVS

Hudson Portfolio Management LLC acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 25,873 shares of the pharmacy operator's stock, valued at approximately $2,677,000. CVS Health comprises about 2.0% of Hudson Portfolio Management LLC's holdings, making the stock its 12th biggest holding.

A number of other institutional investors have also added to or reduced their stakes in CVS. Elevation Wealth Partners LLC raised its position in CVS Health by 41.8% during the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator's stock worth $37,000 after acquiring an additional 105 shares in the last quarter. Apella Capital LLC grew its position in shares of CVS Health by 1.7% in the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator's stock valued at $724,000 after acquiring an additional 117 shares during the period. CYBER HORNET ETFs LLC increased its stake in shares of CVS Health by 4.1% during the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator's stock worth $259,000 after purchasing an additional 134 shares during the last quarter. Northwestern Mutual Investment Management Company LLC lifted its stake in CVS Health by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 40,560 shares of the pharmacy operator's stock valued at $3,219,000 after purchasing an additional 136 shares during the last quarter. Finally, CoreCap Advisors LLC grew its holdings in CVS Health by 4.2% during the second quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator's stock worth $360,000 after purchasing an additional 139 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CVS has been the subject of several research analyst reports. Bank of America lifted their target price on CVS Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Monday, June 22nd. Barclays lifted their price objective on shares of CVS Health from $106.00 to $108.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a report on Thursday, August 6th. Truist Financial increased their price objective on shares of CVS Health from $108.00 to $118.00 and gave the company a "buy" rating in a research report on Tuesday, July 14th. Finally, TD Cowen raised their target price on shares of CVS Health from $105.00 to $110.00 and gave the stock a "buy" rating in a research note on Monday, May 11th. Twenty-two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $107.17.

CVS Health Trading Down 0.7%

Shares of NYSE:CVS opened at $93.01 on Friday. The business's 50 day simple moving average is $102.02 and its 200 day simple moving average is $88.86. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The company has a market capitalization of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analysts' expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.9%. CVS Health's dividend payout ratio is currently 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source